Marten Steen
InvestorManaging Partner at HealthCap · Board director at Mahzi Therapeutics
Stockholm, Sweden
Writes $100K – $5M checks · typically $1.5M
Find your path to Marten
246 people in our graph share verified history with Marten — schools, employers, funds. One of them is your warm intro.
Gustav von SydowunlockedMarten: together at Lund University (1999–2000)
Marten: together at Aro Biotherapeutics
×3Marten: together at Lund University
×2Marten: together at Merck Serono
About
Marten Steen is a board member at AMRA Medical and partner at HealthCap. He previously held positions in business development at Merck Serono and research and development at Novo Nordisk A/S. His experience spans precision medicine, rare diseases, oncology, and venture capital.
Likely email· guessed from name + firm domain, not firm-published
- m•••@healthcap.eureveal70% confident
Board director at Mahzi Therapeutics
Intro paths
→
In turn, Marten can intro founders to Mahzi Therapeutics's investors below.
Mahzi Therapeutics's investors · 5
Co-founders at Mahzi Therapeutics
YW
Yael WeissExecutive Officer, Director
Experience
- AMRA MedicalBoard Membercurrent2026 — presentSweden
- NeobiomicsBoaed Membercurrent2026 — presentSweden
- Kivu BioscienceMember of the Management Boardcurrent2024 — present
- Mahzi TherapeuticsBoard Membercurrent2020 — present
- PriotheraBoard Membercurrent2020 — presentDublin, County Dublin, Ireland
- HealthCapManaging Partnercurrent2010 — present
- Vivet TherapeuticsBoard Membercurrent2018 — presentGreater Paris Metropolitan Region
- PrecirixBoard Membercurrent2018 — presentBrussels Metropolitan Area
- Hemab TherapeuticsBoard Member2021 — 2026Copenhagen, Capital Region of Denmark, Denmark
- Aro BiotherapeuticsBoard Member2021 — 2024Philadelphia, Pennsylvania, United States
- AdcendoBoard Member2021 — 2022Copenhagen, Capital Region of Denmark, Denmark
- Strongbridge Biopharma plcBoard Member2014 — 2021Greater Dublin
- Rainier Therapeutics (Previously BioClin Tx)Board Member2014 — 2020San Francisco Bay Area
- Wilson TherapeuticsBoard Member2012 — 2017Greater Stockholm Metropolitan Area
- Altimmune, Inc.Board Member2015 — 2016London Area, United Kingdom
- Ultragenyx Pharmaceutical Inc.Board Member2011 — 2014San Francisco Bay Area
- FerroKin BioSciencesBoard Member2010 — 2012San Francisco Bay Area
- Merck SeronoDirector Licensing2008 — 2010
- HealthCapMedical Associate2005 — 2008
- Lund University/Novo NordiskResearcher1999 — 2005
Skills & more
Pharmaceutical Industry2Life Sciences1BiotechnologyStrategyVenture Capital1
From Marten's professional profile.
Colleagues at HealthCap
Alex Valcu
Partner at HealthCap
Anki Forsberg
Partner and Chairman at HealthCap
Bjorn Odlander
General Partner at HealthCap
Björn Odlander
Managing Partner at HealthCap
Carl Kilander
Partner at HealthCap
Dag Richter
General Partner at HealthCap
Daniel Karsberg
Partner | MSc at HealthCap
Daniel Schafer
General Partner at HealthCap
Frequently asked questions
- Who is Marten Steen?
- Marten Steen is a board member at AMRA Medical and partner at HealthCap. He previously held positions in business development at Merck Serono and research and development at Novo Nordisk A/S. His experience spans precision medicine, rare diseases, oncology, and venture capital.
- Where does Marten Steen work?
- Marten Steen is Managing Partner at HealthCap and Board director at Mahzi Therapeutics.
- What check size does Marten Steen write?
- Marten Steen typically writes checks of $100K – $5M.
- Where did Marten Steen go to school?
- Marten Steen studied at Lund University (Doctor of Medicine - MD); Lund University (Doctor of Philosophy - PhD, Medicine); Lund University School of Economics and Management (Bachelor of Business Administration - BBA).
Same school
Also attended Lund University137
Alexander Fred-OjalaInvestor at EQT VenturesGustav von SydowInvestor at EQT VenturesRony Patishi-ChillimInvestor at Israel Cleantech VenturesJakob PalmstiernaPresident at GSRMargot HuysmansAnalyst at Heran PartnersAnna HauptInvestor at Industrifonden
+ 131 more
Also attended Lund University School of Economics and Management49
Alexander Fred-OjalaInvestor at EQT VenturesVilton BastiampillaiAssociate – Equity Capital Markets at ScietyJohan ÅkessonInvestment Associate at NordicNinjaClara NorgrenInvestor at IndustrifondenManfred von RichthofenInvestor at Almi InvestLoh Jia YiManager at SGInnovate
+ 43 more
Shared employers
Also worked at Kivu Bioscience1
Also worked at Vivet Therapeutics3
Also worked at Ultragenyx Pharmaceutical Inc.7
Juan CuevaDirector, Early Innovation Partnering at Johnson & Johnson at Joyance PartnersChristina BroomesCommercial Advisor at 2Flo VenturesCarlos SolórzanoPrincipal at S32Linda TsangExecutive Assistant at VenrockCory BystromSenior Director, Biomarker & Analytical Development at AOA DxYael WeissExecutive Officer, Director at Mahzi Therapeutics
+ 1 more
